文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

ICU停用镇痛镇静后意识恢复延迟的决定因素:COVID-19低氧性呼吸衰竭患者的启示

Determinants of Delayed Recovery of Consciousness After Analgosedation Discontinuation in the ICU: Insights From Patients With COVID-19 Hypoxemic Respiratory Failure.
PubMed 文献 · Crit Care Med · 2026-06-15
一句话结论在COVID-19危重患者中,34%达到意识恢复者超出药物合理消除时间,提示意识恢复延迟常非仅由镇静药残留所致。

该回顾性队列研究纳入2020年春夏麻省总医院、威尔康奈尔医学院、哥伦比亚大学欧文医学中心784例COVID-19危重患者,用考虑镇静药特异药代动力学和危重病的模型估算最晚预期意识恢复时间(LERoC)。73%患者出院前意识恢复,但34%达到意识恢复者未在药理上合理的镇静药消除时间内恢复。晚期恢复者更年长,并伴低氧血症和急性肾损伤;使用右美托咪定作为辅助镇静的患者早期恢复比例不成比例地更高;早期与晚期恢复者出院去向无显著差异。作者认为这些数据有助于临床医生和家属对意识恢复的预期,并需研究延迟恢复的其他决定因素。

要点

  • 784例COVID-19危重患者中73%出院前意识恢复,但34%达到恢复者超出药物合理消除时间。
  • 晚期意识恢复者更年长,并伴低氧血症和急性肾损伤。
  • 使用右美托咪定作为辅助镇静的患者早期恢复比例不成比例地更高。
  • 早期与晚期意识恢复者出院去向无显著差异。
  • 作者认为该数据有助于临床医生和家属对意识恢复的预期。

适用人群与场景

  • 2020年春夏在麻省总医院、威尔康奈尔医学院、哥伦比亚大学欧文医学中心收治的784例COVID-19危重病患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入784例COVID-19危重患者,无干预。
  • 主要暴露变量为苯二氮䓬类和/或丙泊酚停药时镇痛镇静药的时间加权剂量,主要结局为意识恢复时间。
  • 73%患者出院前意识恢复,但34%达到意识恢复者未在药理上合理的镇静药消除时间内恢复。
  • 晚期意识恢复者更年长,并伴低氧血症和急性肾损伤。
  • 使用右美托咪定作为辅助镇静的患者早期恢复比例不成比例地更高。
  • 早期与晚期意识恢复者出院去向无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些数据可能有助于临床医生和家属对意识恢复的预期。
  • 作者认为需研究该人群意识恢复延迟的其他决定因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Prolonged disorders of consciousness are common in critically ill patients receiving mechanical ventilation and are often attributed to prolonged sedative exposure in the setting of decreased drug clearance and/or reduced metabolism. Here, in a large sample of critically ill COVID patients obtained over a short period, we tested the assumption that prolonged unconsciousness following benzodiazepine and/or propofol sedation can be attributed to residual exposure. Further, we examine associations between clinical variables on time to recovery of consciousness (RoC) as a framework for the broader critically ill population.

DESIGN: Retrospective cohort study.

SETTING: Massachusetts General Hospital, Weill Cornell Medicine, Columbia University Irving Medical Center.

PATIENTS: Seven hundred eighty-four patients with COVID-19 critical illness in Spring-Summer 2020.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We estimated the latest expected RoC (LERoC) using models of sedation exposure that account for sedative-specific pharmacokinetics and critical illness. Our primary exposure variable was a time-weighted dose of analgosedative agents at benzodiazepine and/or propofol cessation; our primary outcome was time to RoC. We estimated relative risks for late RoC (i.e., after LERoC) via multinomial logistic regression. Among individuals with late RoC, we fit a multivariate subdistribution hazard model for time to RoC. Seventy-three percent of patients had RoC before hospital discharge, yet 34% of patients achieving RoC did not do so within pharmacologically plausible sedative elimination times. Patients with late RoC were older and exhibited hypoxemia and acute kidney injury. Patients with dexmedetomidine as an adjunct sedative had a disproportionately larger incidence of early recovery. Patients with early vs. late RoC did not have significantly different discharge dispositions.

CONCLUSIONS: In our cohort, the time to RoC was commonly prolonged beyond that expected from sedation exposures alone. These data may aid clinicians and families with expectations of RoC and warrant investigation of alternative determinants of delayed RoC in this population.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Safavynia SA, Barra ME, Der Nigoghossian C, et al. Determinants of Delayed Recovery of Consciousness After Analgosedation Discontinuation in the ICU: Insights From Patients With COVID-19 Hypoxemic Respiratory Failure. Crit Care Med. 2026. PMID: 42294965. doi:10.1097/CCM.0000000000007205

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。